Full Transcript Why Perimenopause Changes the GLP-1 Conversation 0:01 I see more and more 0:03 perimenopausal patients 0:03 perimenopausal patients taking semaglutide 0:04 taking semaglutide 0:04 taking semaglutide or tirzepatide ( 0:05 or tirzepatide ( brand names 0:06 brand names 0:06 brand names Ozempic, Vegovi, 0:07 Ozempic, Vegovi, 0:07 Ozempic, Vegovi, Munjaro, and Zepbound) 0:09 Munjaro, and Zepbound) , or asking if they 0:10 , or asking if they 0:10 , or asking if they should start them, and 0:11 should start them, and 0:11 should start them, and their questions about 0:12 their questions about 0:12 their questions about muscle loss, 0:13 muscle loss, 0:13 muscle loss, hormones, and whether 0:15 hormones, and whether 0:15 hormones, and whether hormone therapy affects 0:16 hormone therapy affects 0:16 hormone therapy affects anything are not 0:17 anything are not 0:17 anything are not getting answers anywhere 0:19 getting answers anywhere . This video is the answer 0:21 . This video is the answer 0:21 . This video is the answer to them. Hi, I'm 0:23 to them. Hi, I'm 0:23 to them. Hi, I'm Dr. Elizabeth 0:24 Dr. Elizabeth 0:24 Dr. Elizabeth Tatakin, a 0:25 Tatakin, a naturopathic doctor practicing 0:27 naturopathic doctor practicing 0:27 naturopathic doctor practicing in Phoenix, Arizona, and 0:28 in Phoenix, Arizona, and 0:28 in Phoenix, Arizona, and consulting 0:29 consulting 0:29 consulting nationally and 0:30 nationally and 0:30 nationally and internationally. 0:31 internationally. 0:35 I focus on 0:35 I focus on hormonal 0:36 hormonal 0:36 hormonal health during 0:37 health during 0:37 health during perimenopause, and this 0:39 perimenopause, and this 0:39 perimenopause, and this intersection of 0:40 intersection of 0:40 intersection of GLP-1 ( 0:40 GLP-1 ( glucagon-like 0:41 glucagon-like 0:42 glucagon-like peptide-1) drugs like 0:43 peptide-1) drugs like 0:43 peptide-1) drugs like semaglutide and 0:44 semaglutide and 0:44 semaglutide and tirzepatide with 0:44 tirzepatide with 0:45 tirzepatide with hormonal 0:45 hormonal 0:45 hormonal changes in your 40s is 0:47 changes in your 40s is 0:47 changes in your 40s is something I see in my 0:48 something I see in my 0:48 something I see in my practice every week. By the 0:54 practice every week. By the 0:54 practice every week. By the end of this video, you 0:55 end of this video, you 0:55 end of this video, you will understand how 0:56 will understand how 0:56 will understand how perimenopause 0:57 perimenopause 0:57 perimenopause actually affects 0:58 actually affects 0:58 actually affects the results of taking 0:59 the results of taking 0:59 the results of taking GLP-1, what are the main 1:00 GLP-1, what are the main 1:01 GLP-1, what are the main risks to 1:01 risks to 1:01 risks to consider, and whether you 1:02 consider, and whether you 1:02 consider, and whether you should discuss 1:04 should discuss 1:04 should discuss combining 1:05 combining 1:05 combining GLP-1 with hormone 1:06 GLP-1 with hormone 1:06 GLP-1 with hormone therapy with your doctor. Let's begin. 1:09 therapy with your doctor. Let's begin. 1:10 therapy with your doctor. Let's begin. Semaglutide and 1:10 Semaglutide and 1:10 Semaglutide and tirzepatide 1:11 tirzepatide 1:11 tirzepatide suppress appetite, 1:12 suppress appetite, 1:12 suppress appetite, slow 1:13 slow 1:13 slow gastric emptying, 1:14 gastric emptying, 1:14 gastric emptying, and improve 1:15 and improve 1:17 insulin sensitivity. This is already a 1:17 insulin sensitivity. This is already a well-established 1:18 well-established 1:18 well-established fact. Less understood 1:21 fact. Less understood 1:21 fact. Less understood is how 1:21 is how 1:21 is how perimenopause changes the 1:22 perimenopause changes the 1:23 perimenopause changes the context in which 1:24 context in which 1:24 context in which these medications work. A 1:25 these medications work. A 1:26 these medications work. A 2025 RAND report 1:27 2025 RAND report 1:27 2025 RAND report found that women 1:29 found that women 1:29 found that women aged 50 to 64 1:31 aged 50 to 64 1:31 aged 50 to 64 had the highest 1:32 had the highest 1:32 had the highest rate of 1:33 rate of 1:33 rate of GLP-1 use 1:34 GLP-1 use 1:34 GLP-1 use of all groups. And 1:36 of all groups. And 1:36 of all groups. And women in their 30s and 40s are 1:37 women in their 30s and 40s are 1:37 women in their 30s and 40s are more than 1:38 more than 1:38 more than twice as likely 1:39 twice as likely 1:39 twice as likely to use them 1:40 to use them 1:41 to use them as men of the same 1:42 as men of the same 1:42 as men of the same age. That's the 1:43 age. That's the 1:43 age. That's the problem. These 1:45 problem. These 1:45 problem. These drugs have been studied 1:46 drugs have been studied 1:46 drugs have been studied and dosed for the 1:47 and dosed for the 1:47 and dosed for the general population, 1:48 general population, 1:48 general population, not specifically for 1:49 not specifically for 1:49 not specifically for women going 1:50 women going 1:50 women going through hormonal 1:51 through hormonal 1:52 through hormonal transition. Meanwhile, 1:54 transition. Meanwhile, 1:54 transition. Meanwhile, your perimenopause is 1:56 your perimenopause is 1:56 your perimenopause is already changing your 1:57 already changing your 1:57 already changing your metabolism, your 1:58 metabolism, your 1:58 metabolism, your muscles, your sleep, and where 1:59 muscles, your sleep, and where 1:59 muscles, your sleep, and where your body stores 2:00 your body stores 2:01 your body stores fat. Adding GPP-1 2:03 fat. Adding GPP-1 2:03 fat. Adding GPP-1 to this is not a 2:04 to this is not a 2:04 to this is not a neutral event. I 2:06 neutral event. I 2:07 neutral event. I want to be clear: 2:08 want to be clear: 2:08 want to be clear: this is not a reason to avoid 2:09 this is not a reason to avoid 2:09 this is not a reason to avoid these medications. This is a reason 2:12 these medications. This is a reason 2:12 these medications. This is a reason to understand the 2:12 to understand the 2:12 to understand the specific landscape 2:14 specific landscape in which they 2:14 in which they 2:14 in which they operate for you 2:16 operate for you . The first place where this
The Muscle Loss Risk Most Doctors Miss 2:18 . The first place where this 2:18 . The first place where this landscape matters 2:18 landscape matters 2:18 landscape matters the most is in the 2:20 the most is in the 2:20 the most is in the muscles. This is precisely where the 2:21 muscles. This is precisely where the 2:21 muscles. This is precisely where the risk lies for 2:23 risk lies for 2:24 perimenopausal women. 2:25 perimenopausal women. Muscle loss is not a 2:26 Muscle loss is not a 2:26 Muscle loss is not a new phenomenon in your 30s and 2:28 new phenomenon in your 30s and 2:28 new phenomenon in your 30s and 40s. Women 2:29 40s. Women 2:29 40s. Women lose approximately 2:31 lose approximately 2:31 lose approximately 3 to 8% of their muscle 2:32 3 to 8% of their muscle 2:32 3 to 8% of their muscle mass per decade, 2:34 mass per decade, 2:34 mass per decade, starting in their 30s. And 2:35 starting in their 30s. And 2:35 starting in their 30s. And after 50 years, this 2:37 after 50 years, this 2:37 after 50 years, this rate increases to 5–10% 2:39 rate increases to 5–10% per decade. 2:40 per decade. 2:41 per decade. Declining 2:41 Declining 2:41 Declining estrogen levels are a major 2:43 estrogen levels are a major 2:43 estrogen levels are a major factor in this 2:44 factor in this 2:44 factor in this acceleration. 2:44 acceleration. 2:46 The drug GLP-1 2:46 The drug GLP-1 creates a 2:47 creates a 2:47 creates a calorie deficit by 2:48 calorie deficit by 2:49 calorie deficit by suppressing appetite. 2:50 suppressing appetite. 2:52 When this deficit is not 2:52 When this deficit is not 2:54 carefully controlled, the weight you 2:54 carefully controlled, the weight you lose is not 2:55 lose is not 2:55 lose is not just fat. This also 2:57 just fat. This also 2:57 just fat. This also includes muscles. And here's 2:58 includes muscles. And here's 2:58 includes muscles. And here's where the situation 2:59 where the situation 2:59 where the situation gets worse. 3:00 gets worse. 3:00 gets worse. Estrogen decreases, 3:01 Estrogen decreases, 3:01 Estrogen decreases, calories are restricted, 3:03 calories are restricted, 3:03 calories are restricted, and protein intake 3:04 and protein intake 3:04 and protein intake also tends 3:05 also tends 3:05 also tends to decrease because 3:06 to decrease because 3:06 to decrease because with GLP-1 you don't 3:07 with GLP-1 you don't 3:07 with GLP-1 you don't feel as 3:08 feel as 3:08 feel as hungry. 3:09 hungry. 3:10 hungry. Combine these three 3:11 Combine these three 3:11 Combine these three factors, and the conditions for 3:12 factors, and the conditions for 3:12 factors, and the conditions for muscle loss 3:13 muscle loss 3:13 muscle loss will work against 3:14 will work against 3:14 will work against you simultaneously. This is 3:15 you simultaneously. This is 3:15 you simultaneously. This is important because 3:16 important because 3:16 important because muscle is metabolically 3:18 muscle is metabolically 3:18 muscle is metabolically active tissue. 3:19 active tissue. 3:19 active tissue. Less muscle means a 3:20 Less muscle means a 3:20 Less muscle means a lower 3:21 lower 3:21 lower resting metabolic rate 3:22 resting metabolic rate 3:22 resting metabolic rate , which makes it harder 3:23 , which makes it harder 3:23 , which makes it harder to maintain 3:25 to maintain 3:25 to maintain weight over time, not 3:26 weight over time, not 3:26 weight over time, not easier. I remember one of 3:27 easier. I remember one of 3:27 easier. I remember one of my patients. She 3:29 my patients. She 3:29 my patients. She was 48 years old and 3:30 was 48 years old and 3:30 was 48 years old and came to me with the 3:31 came to me with the 3:32 came to me with the goal of losing 50 3:33 goal of losing 50 3:33 goal of losing 50 pounds. Along with this are 3:34 pounds. Along with this are the symptoms 3:35 the symptoms 3:35 the symptoms of perimenopause. The weight 3:37 of perimenopause. The weight 3:37 of perimenopause. The weight was coming off, but she 3:38 was coming off, but she 3:38 was coming off, but she told me she 3:39 told me she 3:39 told me she just couldn't 3:40 just couldn't 3:40 just couldn't live like this anymore. She had 3:42 live like this anymore. She had 3:42 live like this anymore. She had no energy at all. 3:43 no energy at all. 3:43 no energy at all. Even though 3:44 Even though 3:44 Even though the scale was moving 3:45 the scale was moving 3:45 the scale was moving in the right 3:46 in the right 3:46 in the right direction, this 3:47 direction, this 3:47 direction, this discrepancy— 3:48 discrepancy— weight loss without 3:49 weight loss without 3:49 weight loss without energy—became a 3:49 energy—became a 3:49 energy—became a red flag. 3:51 red flag. 3:51 red flag. We increased 3:51 We increased 3:51 We increased protein and 3:53 protein and 3:53 protein and amino acid intake, added 3:54 amino acid intake, added 3:54 amino acid intake, added strength training, 3:55 strength training, 3:55 strength training, started 3:56 started 3:56 started progesterone, and 3:57 progesterone, and 3:57 progesterone, and adjusted the GLP 3:58 adjusted the GLP -1 dose. After 3 months, she 4:00 -1 dose. After 3 months, she 4:00 -1 dose. After 3 months, she felt more 4:01 felt more 4:01 felt more energy, strength, 4:02 energy, strength, 4:02 energy, strength, slept better, and was in a better 4:04 slept better, and was in a better 4:04 slept better, and was in a better mood. Once 4:05 mood. Once 4:05 mood. Once she was ready for 4:06 she was ready for 4:06 she was ready for change, all of these elements 4:07 change, all of these elements 4:07 change, all of these elements quickly came together 4:08 quickly came together 4:08 quickly came together . So, 4:09 . So, 4:09 . So, the number on the scale can 4:10 the number on the scale can 4:10 the number on the scale can be misleading. 4:11 be misleading. 4:11 be misleading. Weight loss while 4:12 Weight loss while 4:12 Weight loss while taking GLP-1, which 4:13 taking GLP-1, which 4:13 taking GLP-1, which occurs 4:14 occurs 4:14 occurs mainly at the expense of 4:15 mainly at the expense of 4:15 mainly at the expense of muscle, is a step 4:16 muscle, is a step 4:16 muscle, is a step back for 4:16 back for 4:16 back for metabolism, not a 4:17 metabolism, not a 4:17 metabolism, not a victory. 4:19 victory. 4:19 victory. There is a solution to this problem,
The Research on GLP-1s and Hormone Therapy 4:20 There is a solution to this problem, 4:20 There is a solution to this problem, and it is directly 4:21 and it is directly 4:21 and it is directly related to the 4:21 related to the 4:21 related to the hormonal 4:22 hormonal 4:22 hormonal aspect, which 4:23 aspect, which 4:23 aspect, which fundamentally changes this 4:24 fundamentally changes this 4:24 fundamentally changes this discussion. In April 2024, a 4:25 discussion. In April 2024, a 4:29 study was published in the journal Menopause 4:29 study was published in the journal Menopause involving postmenopausal women 4:30 involving postmenopausal women 4:32 taking semaglutide; 4:32 taking semaglutide; Those who 4:34 Those who 4:34 Those who also underwent 4:35 also underwent 4:35 also underwent hormone therapy were compared 4:36 hormone therapy were compared 4:36 hormone therapy were compared with those who did not 4:37 with those who did not 4:37 with those who did not . After 3 4:38 . After 3 4:38 . After 3 months, the 4:39 months, the 4:39 months, the hormone therapy group 4:41 hormone therapy group 4:41 hormone therapy group lost 7% of their body weight 4:43 lost 7% of their body weight 4:43 lost 7% of their body weight compared to 5% in the group 4:44 compared to 5% in the group 4:44 compared to 5% in the group without such therapy. 4:46 without such therapy. 4:46 without such therapy. After 12 months, this 4:48 After 12 months, this 4:48 After 12 months, this gap 4:50 gap 4:50 gap had widened even further: 16% versus 12% 4:52 had widened even further: 16% versus 12% . Why 4:54 . Why 4:54 . Why does hormone therapy make GLP-1 4:55 does hormone therapy make GLP-1 4:55 does hormone therapy make GLP-1 more effective? One 4:57 more effective? One 4:57 more effective? One mechanism is 4:58 mechanism is 4:58 mechanism is that estrogen 4:59 that estrogen 4:59 that estrogen enhances 5:01 enhances 5:01 enhances GLP-1 receptor signaling in the 5:02 GLP-1 receptor signaling in the 5:02 GLP-1 receptor signaling in the same areas of the brain 5:03 same areas of the brain 5:03 same areas of the brain that regulate appetite. 5:05 that regulate appetite. 5:05 that regulate appetite. When estrogen 5:06 When estrogen 5:06 When estrogen is present, this 5:07 is present, this 5:07 is present, this signaling 5:08 signaling 5:08 signaling seems to work more 5:09 seems to work more 5:09 seems to work more effectively. 5:10 effectively. 5:10 effectively. Hormone therapy 5:11 Hormone therapy 5:11 Hormone therapy also tends to 5:12 also tends to 5:12 also tends to improve sleep quality, 5:13 improve sleep quality, 5:14 improve sleep quality, and better sleep 5:14 and better sleep 5:14 and better sleep helps regulate the 5:16 helps regulate the 5:16 helps regulate the hunger hormones 5:17 hunger hormones ghrelin and leptin. This is 5:19 ghrelin and leptin. This is 5:19 ghrelin and leptin. This is another factor in 5:20 another factor in 5:20 another factor in your favor, and 5:22 your favor, and 5:22 your favor, and estrogen itself helps 5:23 estrogen itself helps 5:23 estrogen itself helps preserve muscle mass 5:24 preserve muscle mass , which directly 5:25 , which directly 5:25 , which directly eliminates the risk of 5:26 eliminates the risk of 5:26 eliminates the risk of muscle loss we just 5:28 muscle loss we just 5:28 muscle loss we just talked about. There are no 5:30 talked about. There are no 5:30 talked about. There are no known 5:31 known 5:31 known direct drug 5:32 direct drug 5:32 direct drug interactions between 5:32 interactions between 5:32 interactions between semaglutide and 5:33 semaglutide and 5:33 semaglutide and standard 5:34 standard 5:34 standard 5:36 hormone therapy medications . One practical 5:37 . One practical 5:37 . One practical point to be 5:38 point to be 5:38 point to be aware of: because 5:39 aware of: because 5:39 aware of: because GLP-1 drugs 5:40 GLP-1 drugs 5:40 GLP-1 drugs slow 5:41 slow 5:41 slow gastric emptying, the 5:42 gastric emptying, the 5:42 gastric emptying, the absorption of 5:43 absorption of 5:43 absorption of oral 5:44 oral 5:44 oral hormonal 5:44 hormonal 5:45 hormonal drugs may be 5:46 drugs may be 5:46 drugs may be impaired. 5:46 impaired. 5:47 impaired. Transdermal 5:48 Transdermal 5:48 Transdermal patches, gels, creams, 5:49 patches, gels, creams, 5:49 patches, gels, creams, and vaginal forms 5:50 and vaginal forms 5:50 and vaginal forms completely solve 5:51 completely solve 5:52 completely solve this problem. This does 5:53 this problem. This does 5:53 this problem. This does not mean that 5:54 not mean that 5:54 not mean that every woman 5:55 every woman 5:55 every woman taking GLP-1 during 5:56 taking GLP-1 during 5:56 taking GLP-1 during perimenopause 5:57 perimenopause 5:57 perimenopause should receive 5:58 should receive 5:58 should receive hormone therapy. 6:00 hormone therapy. 6:00 hormone therapy. This means that these two 6:01 This means that these two 6:01 This means that these two topics should definitely 6:02 topics should definitely 6:02 topics should definitely be considered together, 6:03 be considered together, 6:03 be considered together, not in isolation 6:04 not in isolation 6:04 not in isolation from each other. If this 6:07 from each other. If this 6:07 from each other. If this changes your perspective on the 6:08 changes your perspective on the 6:08 changes your perspective on the destination, leave 6:09 destination, leave 6:10 destination, leave a comment below. I would be 6:11 a comment below. I would be 6:11 a comment below. I would be interested 6:12 interested 6:12 interested to hear about your 6:13 to hear about your 6:13 to hear about your experience. And if you want 6:14 experience. And if you want 6:14 experience. And if you want more 6:15 more 6:15 more content like this, 6:16 content like this, subscribe. This 6:17 subscribe. This 6:17 subscribe. This channel covers 6:18 channel covers 6:18 channel covers 6:19 naturopathic and 6:19 naturopathic and functional 6:20 functional 6:20 functional medicine issues in the field of 6:21 medicine issues in the field of 6:21 medicine issues in the field of women's and 6:22 women's and 6:22 women's and family health. 6:23 family health. 6:23 family health. And now I'm going to delve into the 6:24 And now I'm going to delve into the 6:24 And now I'm going to delve into the topics of 6:25 topics of 6:25 topics of perimenopause and 6:26 perimenopause and 6:26 perimenopause and menopause. You won't 6:27 menopause. You won't 6:27 menopause. You won't want to miss what 6:28 want to miss what 6:28 want to miss what comes next. 6:29 comes next. 6:29 comes next. GLP-1 drugs
Protein Needs on a GLP-1 in Perimenopause 6:30 GLP-1 drugs 6:30 GLP-1 drugs reduce appetite. When 6:32 reduce appetite. When 6:32 reduce appetite. When you eat less overall 6:33 you eat less overall , protein is often the first thing 6:35 , protein is often the first thing 6:35 , protein is often the first thing to drop from your diet because 6:36 to drop from your diet because 6:36 to drop from your diet because protein-rich foods can 6:37 protein-rich foods can 6:37 protein-rich foods can feel heavy 6:38 feel heavy 6:38 feel heavy when you're not very 6:39 when you're not very 6:39 when you're not very hungry. During 6:41 hungry. During 6:41 hungry. During perimenopause, your 6:42 perimenopause, your 6:42 perimenopause, your protein needs are already 6:43 protein needs are already 6:43 protein needs are already higher than standard 6:45 higher than standard 6:45 higher than standard recommendations. 6:45 recommendations. 6:46 recommendations. Studies suggest 6:48 Studies suggest 6:48 Studies suggest 1.2–1.6 g per kilogram of 6:50 1.2–1.6 g per kilogram of 6:50 1.2–1.6 g per kilogram of body weight per day, 6:51 body weight per day, 6:51 body weight per day, compared to the 6:52 compared to the 6:53 compared to the standard 0.8 g. When 6:54 standard 0.8 g. When 6:54 standard 0.8 g. When taking GLP-1, 6:55 taking GLP-1, 6:56 taking GLP-1, achieving this goal 6:57 achieving this goal 6:57 achieving this goal requires conscious 6:59 requires conscious 6:59 requires conscious effort. This is not something that 7:00 effort. This is not something that 7:00 effort. This is not something that happens 7:01 happens 7:01 happens by chance when you 7:02 by chance when you 7:02 by chance when you consume 7:03 consume 7:03 consume less food overall. The rule 7:05 less food overall. The rule 7:05 less food overall. The rule I give my 7:06 I give my 7:06 I give my patients is simple. 7:07 patients is simple. 7:07 patients is simple. Protein—first and foremost 7:08 Protein—first and foremost 7:08 Protein—first and foremost at every 7:09 at every 7:09 at every meal: before 7:10 meal: before 7:10 meal: before carbohydrates, before fats. 7:12 carbohydrates, before fats. 7:12 carbohydrates, before fats. Meet your 7:13 Meet your 7:13 Meet your protein quota, then 7:14 protein quota, then 7:14 protein quota, then fill up the rest of 7:15 fill up the rest of 7:15 fill up the rest of your plate. Strength 7:16 your plate. Strength 7:16 your plate. Strength training is the second 7:17 training is the second 7:17 training is the second half of success. 7:18 half of success. 7:18 half of success. Strength training two to
Resistance Training and Digestive Support 7:19 Strength training two to three times a week 7:20 three times a week 7:20 three times a week signals the body 7:21 signals the body 7:21 signals the body to use this 7:22 to use this 7:22 to use this protein to 7:23 protein to 7:23 protein to build and 7:24 build and 7:24 build and maintain muscle, 7:25 maintain muscle, 7:25 maintain muscle, rather than simply burning 7:26 rather than simply burning 7:26 rather than simply burning it as fuel. A 7:27 it as fuel. A 7:27 it as fuel. A few more mandatory 7:28 few more mandatory 7:28 few more mandatory points that I 7:29 points that I 7:29 points that I implement in every 7:30 implement in every 7:30 implement in every protocol. 7:32 protocol. 7:32 protocol. Prioritize nutrient 7:33 Prioritize nutrient 7:33 Prioritize nutrient density over 7:34 density over 7:34 density over food volume. Since you're 7:35 food volume. Since you're 7:35 food volume. Since you're eating less overall, 7:36 eating less overall, 7:36 eating less overall, every bite 7:37 every bite 7:37 every bite counts. Combine 7:39 counts. Combine 7:39 counts. Combine fiber with 7:40 fiber with 7:40 fiber with plenty of 7:41 plenty of 7:41 plenty of water, as GLP-1 already 7:42 water, as GLP-1 already 7:42 water, as GLP-1 already slows digestion 7:44 slows digestion , and fiber without 7:45 , and fiber without 7:45 , and fiber without fluid can make it 7:46 fluid can make it 7:46 fluid can make it worse. Eat 7:47 worse. Eat 7:47 worse. Eat slowly and 7:48 slowly and 7:48 slowly and chew thoroughly. This 7:49 chew thoroughly. This 7:49 chew thoroughly. This helps reduce 7:50 helps reduce 7:50 helps reduce digestive discomfort 7:51 digestive discomfort 7:51 digestive discomfort that often 7:52 that often 7:52 that often occurs with these 7:53 occurs with these 7:53 occurs with these medications. 7:54 medications. 7:54 medications. Digestive support is 7:55 Digestive support is 7:55 Digestive support is also important here 7:56 also important here 7:56 also important here . Bitter herbs 7:57 . Bitter herbs 7:57 . Bitter herbs and digestive enzymes 7:58 and digestive enzymes 7:58 and digestive enzymes can help 7:59 can help 7:59 can help when nausea or early 8:00 when nausea or early 8:00 when nausea or early satiety limits 8:02 satiety limits 8:02 satiety limits the amount of food you 8:03 the amount of food you 8:03 the amount of food you can eat. And 8:04 can eat. And 8:04 can eat. And because these medications 8:05 because these medications 8:05 because these medications slow down 8:06 slow down 8:06 slow down motility, I often 8:07 motility, I often 8:07 motility, I often add special 8:08 add special 8:08 add special support for 8:09 support for 8:09 support for regular 8:10 regular 8:10 regular bowel movements. A soluble 8:11 bowel movements. A soluble 8:11 bowel movements. A soluble fiber 8:12 fiber 8:12 fiber called "sun fiber" 8:14 called "sun fiber" 8:14 called "sun fiber" and the Ayurvedic 8:14 and the Ayurvedic 8:14 and the Ayurvedic herbal blend " 8:15 herbal blend " triphala," which has a 8:16 triphala," which has a 8:16 triphala," which has a long history of 8:17 long history of 8:17 long history of supporting healthy 8:18 supporting healthy 8:18 supporting healthy toxin elimination. And 8:20 toxin elimination. And 8:20 toxin elimination. And this point surprises 8:21 this point surprises 8:21 this point surprises people. I usually 8:23 people. I usually 8:23 people. I usually recommend 8:24 recommend 8:24 recommend taking the 8:25 taking the 8:25 taking the peptide itself cyclically—with breaks 8:26 peptide itself cyclically—with breaks 8:26 peptide itself cyclically—with breaks under the supervision of your 8:28 under the supervision of your 8:28 under the supervision of your doctor. This applies to 8:30 doctor. This applies to 8:30 doctor. This applies to semaglutide and 8:31 semaglutide and 8:31 semaglutide and tirzepatide as well as 8:32 tirzepatide as well as 8:32 tirzepatide as well as other peptides. 8:33 other peptides. 8:34 other peptides. Cyclicity 8:34 Cyclicity 8:35 Cyclicity helps to find 8:36 helps to find 8:36 helps to find the lowest effective 8:37 the lowest effective 8:37 the lowest effective dose, instead of 8:38 dose, instead of 8:38 dose, instead of staying at a 8:39 staying at a 8:39 staying at a fixed dose 8:40 fixed dose 8:40 fixed dose indefinitely, and sometimes 8:41 indefinitely, and sometimes 8:41 indefinitely, and sometimes even constantly 8:42 even constantly 8:42 even constantly increasing it. By 8:45 increasing it. By 8:45 increasing it. By combining protein, 8:46 combining protein, 8:46 combining protein, strength training, 8:47 strength training, 8:47 strength training, digestive support, 8:48 digestive support, 8:48 digestive support, and 8:49 and 8:49 and cycling to the 8:50 cycling to the 8:50 cycling to the minimum 8:50 minimum 8:50 minimum effective dose, you are 8:52 effective dose, you are 8:52 effective dose, you are giving your body what it 8:53 giving your body what it 8:53 giving your body what it needs to 8:53 needs to 8:53 needs to preserve muscle and 8:54 preserve muscle and 8:54 preserve muscle and control the 8:55 control the 8:55 control the drug, not the 8:56 drug, not the 8:56 drug, not the other way around. If you are 8:58 other way around. If you are 8:58 other way around. If you are
What to Ask Your Doctor at Your Next Appointment 9:00 perimenopausal and 9:00 perimenopausal and considering 9:01 considering 9:01 considering taking GLP 9:02 taking GLP -1, ask about it. 9:03 -1, ask about it. 9:04 -1, ask about it. Do we also 9:04 Do we also 9:04 Do we also discuss my 9:05 discuss my 9:05 discuss my hormone levels and whether 9:06 hormone levels and whether 9:09 hormone therapy is appropriate for me? 9:09 hormone therapy is appropriate for me? If you are already taking 9:10 If you are already taking 9:10 If you are already taking GLP-1, ask about it. 9:12 GLP-1, ask about it. 9:12 GLP-1, ask about it. Should we 9:13 Should we 9:13 Should we track my 9:14 track my 9:14 track my muscle mass and not 9:15 muscle mass and not 9:15 muscle mass and not just my weight so we 9:16 just my weight so we 9:16 just my weight so we know we're losing 9:17 know we're losing 9:17 know we're losing fat and not muscle? DEXA 9:20 fat and not muscle? DEXA scans or 9:21 scans or 9:21 scans or body composition analysis 9:22 body composition analysis 9:22 body composition analysis provide much more 9:23 provide much more 9:23 provide much more useful information 9:24 useful information than just your weight on the 9:26 than just your weight on the 9:26 than just your weight on the scale. Libra can't 9:28 scale. Libra can't 9:28 scale. Libra can't tell you 9:29 tell you 9:29 tell you what you're really 9:30 what you're really 9:30 what you're really missing. Several 9:31 missing. Several 9:31 missing. Several prerequisites for 9:33 prerequisites for 9:33 prerequisites for your visit to 9:34 your visit to 9:34 your visit to the doctor. Daily 9:35 the doctor. Daily 9:35 the doctor. Daily protein intake. 9:36 protein intake. 9:39 Strength training 9:39 Strength training two to three times a 9:39 two to three times a 9:40 two to three times a week and regular 9:41 week and regular 9:41 week and regular check-ups every 4-6 9:42 check-ups every 4-6 9:42 check-ups every 4-6 weeks, not just an 9:43 weeks, not just an 9:43 weeks, not just an automatic 9:44 automatic 9:44 automatic prescription renewal. 9:45 prescription renewal. 9:48 If 9:48 If hormone 9:50 hormone 9:50 hormone therapy and GLP-1 are on the agenda, know 9:51 therapy and GLP-1 are on the agenda, know 9:51 therapy and GLP-1 are on the agenda, know the following. Both 9:52 the following. Both 9:52 the following. Both options have a 9:53 options have a 9:53 options have a high 9:54 high 9:54 high safety profile separately 9:55 safety profile separately 9:55 safety profile separately from each other. What matters 9:56 from each other. What matters 9:56 from each other. What matters most is 9:58 most is 9:58 most is your personal 9:58 your personal 9:58 your personal risk factors, and this is a 10:00 risk factors, and this is a 10:00 risk factors, and this is a question worth 10:00 question worth 10:01 question worth discussing with your 10:02 discussing with your 10:02 discussing with your doctor. None of this 10:04 doctor. None of this 10:04 doctor. None of this replaces 10:04 replaces 10:04 replaces 10:07 fundamentals. GLP-1 can be a 10:07 fundamentals. GLP-1 can be a useful 10:07 useful 10:07 useful tool, but it 10:09 tool, but it 10:09 tool, but it works best when the 10:10 works best when the 10:10 works best when the basic foundations are already 10:11 basic foundations are already 10:11 basic foundations are already laid. 10:13 laid. 10:13 laid. Nutrient-rich food 10:14 Nutrient-rich food 10:14 Nutrient-rich food and adequate 10:15 and adequate 10:15 and adequate protein. Exercise, 10:17 protein. Exercise, 10:17 protein. Exercise, especially strength 10:18 especially strength 10:18 especially strength training, and 10:19 training, and 10:19 training, and quality sleep, which 10:20 quality sleep, which 10:20 quality sleep, which perimenopause already 10:22 perimenopause already 10:22 perimenopause already disrupts. 10:24 disrupts. 10:24 disrupts. Stress management, as 10:25 Stress management, as 10:25 Stress management, as cortisol affects both 10:26 cortisol affects both 10:28 blood sugar levels and muscles. 10:29 blood sugar levels and muscles. And also analyzing your 10:30 And also analyzing your 10:30 And also analyzing your environment—daily 10:31 environment—daily 10:32 environment—daily actions and habits that either 10:33 actions and habits that either 10:33 actions and habits that either support your 10:34 support your 10:34 support your hormones or work 10:35 hormones or work 10:35 hormones or work against them. These basics are 10:38 against them. These basics are not additional options 10:39 not additional options 10:39 not additional options that are superimposed 10:40 that are superimposed 10:40 that are superimposed on top of medication. This is the 10:43 on top of medication. This is the 10:43 on top of medication. This is the true approach: 10:44 true approach: 10:44 true approach: give the body what it 10:46 give the body what it 10:46 give the body what it needs and eliminate what gets in 10:47 needs and eliminate what gets in 10:47 needs and eliminate what gets in the way. So GLP-1 10:50 the way. So GLP-1 10:50 the way. So GLP-1 becomes a bridge to 10:51 becomes a bridge to 10:51 becomes a bridge to lasting change, not 10:53 lasting change, not 10:53 lasting change, not something you 10:54 something you 10:54 something you will depend on 10:55 will depend on 10:55 will depend on indefinitely. 10:56 indefinitely. 10:59 GLP-1 drugs may 10:59 GLP-1 drugs may be effective for 11:00 be effective for 11:02 perimenopausal women, but the 11:02 perimenopausal women, but the context of perimenopause changes both the 11:04 context of perimenopause changes both the 11:04 context of perimenopause changes both the risk profile and the 11:05 risk profile and the 11:05 risk profile and the strategy. Three things to 11:06 strategy. Three things to 11:09 consider. The risk of 11:09 consider. The risk of muscle loss is 11:10 muscle loss is 11:10 muscle loss is specific to 11:11 specific to 11:11 specific to this stage. 11:11 this stage. 11:11 this stage. Protect it 11:12 Protect it 11:12 Protect it with protein and 11:13 with protein and 11:13 with protein and strength training. 11:14 strength training. 11:15 strength training. Studies 11:16 Studies 11:16 Studies suggest measurable synergy 11:17 suggest measurable synergy 11:17 suggest measurable synergy between hormone 11:19 between hormone 11:19 between hormone therapy and GLP-1. 11:20 therapy and GLP-1. 11:20 therapy and GLP-1. More weight loss, 11:21 More weight loss, 11:21 More weight loss, better results—these 11:22 better results—these 11:22 better results—these issues should be 11:23 issues should be 11:23 issues should be discussed together. 11:24 discussed together. 11:25 discussed together. Ask your doctor 11:26 Ask your doctor 11:26 Ask your doctor to track your 11:27 to track your 11:27 to track your body composition, not just your weight, 11:28 body composition, not just your weight, 11:28 body composition, not just your weight, so you understand exactly what 11:30 so you understand exactly what 11:30 so you understand exactly what you're losing. 11:31 you're losing. 11:31 you're losing. Your body knows how to 11:32 Your body knows how to 11:32 Your body knows how to heal itself. I'm here 11:34 heal itself. I'm here 11:34 heal itself. I'm here to help 11:35 to help 11:35 to help remove what's standing 11:36 remove what's standing 11:36 remove what's standing in the way. I'm also 11:37 in the way. I'm also 11:37 in the way. I'm also preparing a video about protein 11:39 preparing a video about protein 11:39 preparing a video about protein and perimenopause: 11:40 and perimenopause: 11:40 and perimenopause: how much, when, and why 11:42 how much, when, and why 11:42 how much, when, and why it becomes even more important 11:43 it becomes even more important 11:43 it becomes even more important when taking GLP-1. 11:45 when taking GLP-1. 11:45 when taking GLP-1. It will be released soon. The 11:47 It will be released soon. The 11:47 It will be released soon. The first step today is 11:48 first step today is 11:48 first step today is very simple. 11:49 very simple. 11:52 Discuss questions 11:52 Discuss questions about GLP-1 and hormones with your 11:53 about GLP-1 and hormones with your 11:53 about GLP-1 and hormones with your doctor at one 11:55 doctor at one 11:55 doctor at one appointment. These are 11:56 appointment. These are 11:56 appointment. These are inseparable things. If 11:58 inseparable things. If 11:58 inseparable things. If you're looking for honest, 11:59 you're looking for honest, 12:01 evidence-based information about what 12:02 evidence-based information about what really 12:02 really 12:02 really happens during 12:03 happens during 12:03 happens during perimenopause and how to 12:05 perimenopause and how to 12:05 perimenopause and how to get through it, 12:05 get through it, 12:05 get through it, subscribe so you don't 12:07 subscribe so you don't 12:07 subscribe so you don't miss out. New 12:08 miss out. New 12:08 miss out. New videos every week. And if 12:10 videos every week. And if 12:10 videos every week. And if you need 12:11 you need 12:11 you need help putting 12:12 help putting 12:12 help putting this into practice, you 12:14 this into practice, you 12:14 this into practice, you can learn 12:15 can learn 12:15 can learn more about working with 12:16 more about working with 12:16 more about working with me on my website 12:18 me on my website 12:18 me on my website drlizabethtakin.com. Take care 12:20 drlizabethtakin.com. Take care 12:20 drlizabethtakin.com. Take care , see you in the 12:21 , see you in the 12:21 , see you in the next video.
Comments